+ Follow PREVENTION STUDY Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 255962
[Title] => Affordable ACE inhibitor launched
[Summary] => More than seven million Filipinos have high blood pressure, according to a study by the Philippine Society of Hypertension. However, only one of every 10 hypertensive individuals is receiving adequate treatment. The main reason: the high cost of anti-hypertensive medicines.
Pascual Laboratories Inc., a fast-growing national pharmaceutical company, recently launched a more affordable enalapril, an antihypertensive drug belonging to the ACE (angiotensin-converting enzyme) inhibitor group
[DatePublished] => 2004-07-01 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
PREVENTION STUDY
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 255962
[Title] => Affordable ACE inhibitor launched
[Summary] => More than seven million Filipinos have high blood pressure, according to a study by the Philippine Society of Hypertension. However, only one of every 10 hypertensive individuals is receiving adequate treatment. The main reason: the high cost of anti-hypertensive medicines.
Pascual Laboratories Inc., a fast-growing national pharmaceutical company, recently launched a more affordable enalapril, an antihypertensive drug belonging to the ACE (angiotensin-converting enzyme) inhibitor group
[DatePublished] => 2004-07-01 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest